Barry S. Taylor
Barry S. Taylor
Loxo Oncology, Eli Lilly
بريد إلكتروني تم التحقق منه على loxooncology.com - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Comprehensive molecular portraits of human breast tumours
CGAR Network
Nature 490 (7418), 61-70, 2012
68942012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R McLendon, A Friedman, D Bigner, EG Van Meir, DJ Brat, ...
Nature 455 (7216), 1061-1068, 2008
52992008
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
45812012
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
45222011
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113, 2013
34482013
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
30122010
Integrated genomic characterization of endometrial carcinoma
DA Levine, Cancer Genome Atlas Research Network
Nature 497 (7447), 67-73, 2013
24862013
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
24742012
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543-550, 2014
24572014
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network
Nature 499 (7456), 43-49, 2013
17102013
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703, 2017
12132017
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
BE Johnson, T Mazor, C Hong, M Barnes, K Aihara, CY McLean, ...
Science 343 (6167), 189-193, 2014
9182014
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
7352018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
6172018
Genome sequencing identifies a basis for everolimus sensitivity
G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ...
Science 338 (6104), 221, 2012
6172012
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715, 2010
5762010
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ...
Nature genetics 43 (7), 668-672, 2011
5502011
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
5192017
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
JC King, J Xu, J Wongvipat, H Hieronymus, BS Carver, DH Leung, ...
Nature genetics 41 (5), 524-526, 2009
4982009
Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled …
H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ...
Journal of Clinical Oncology 36 (7), 633, 2018
4952018
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20